News | January 03, 2024
Strides Pharma Science to invest in AMP-6, AMP-8
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
Sirius JV will be owned 51% by Sirius and 49% by Adani
Furthering cell therapy ambition across oncology and autoimmune diseases
The plant is yet to start commercial operations
Receives registration of Valganciclovir powder for oral solution in Germany
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
New facility is part of Aptar Pharma’s global expansion program
Subscribe To Our Newsletter & Stay Updated
